413 related articles for article (PubMed ID: 18670306)
1. Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer.
Ou SH; Zell JA
J Thorac Oncol; 2008 Aug; 3(8):880-6. PubMed ID: 18670306
[TBL] [Abstract][Full Text] [Related]
2. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
[TBL] [Abstract][Full Text] [Related]
3. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
[TBL] [Abstract][Full Text] [Related]
4. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer?
David EA; Cooke DT; Chen Y; Nijar K; Canter RJ; Cress RD
Ann Thorac Surg; 2017 Jan; 103(1):226-235. PubMed ID: 27469339
[TBL] [Abstract][Full Text] [Related]
5. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
8. Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients.
Samayoa AX; Pezzi TA; Pezzi CM; Greer Gay E; Asai M; Kulkarni N; Carp N; Chun SG; Putnam JB
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1005-1011. PubMed ID: 27531307
[TBL] [Abstract][Full Text] [Related]
9. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
11. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
[TBL] [Abstract][Full Text] [Related]
12. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
[TBL] [Abstract][Full Text] [Related]
13. Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy.
Zhou H; Tapias LF; Gaissert HA; Muniappan A; Wright CD; Wain JC; Donahue DM; Morse CR; Mathisen DJ; Lanuti M
Ann Thorac Surg; 2015 Sep; 100(3):910-6. PubMed ID: 26165483
[TBL] [Abstract][Full Text] [Related]
14. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
[TBL] [Abstract][Full Text] [Related]
15. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
[TBL] [Abstract][Full Text] [Related]
16. Frequency and prognostic significance of preoperatively detected enlarged regional lymph nodes in patients with pathological stage I non-small cell lung cancer following resection.
Hoang JK; Patz E; Giroux D; Goldstraw P
J Thorac Oncol; 2007 Dec; 2(12):1103-6. PubMed ID: 18090582
[TBL] [Abstract][Full Text] [Related]
17. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
Zhang GQ; Han F; Gao SL; A DL; Pang ZL
Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
19. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.
Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H
World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195
[TBL] [Abstract][Full Text] [Related]
20. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
